TGA / PMDA / NMPA · Asia-Pacific
extracellular — TGA / PMDA / NMPA regulatory status
extracellular regulatory status in the Asia-Pacific is tracked from public TGA / PMDA / NMPA records and cross-linked clinical and patent datasets on NovaPharmaNews. Current status: NMPA clinical trials.
Status snapshot
- Status
- NMPA clinical trials
- Structured fields
- 4
Regional decision snapshot — NMPA: clinical trials.
Linked evidence on this spoke: 5 published clinical programs and 12 related patent records. Use the tables below for NCT identifiers, phases, and exclusivity dates; verify against primary sources before BD or medical decisions.
Regulatory timeline
| Regulator | Region | Status | Date | Source |
|---|---|---|---|---|
| NMPA | China | clinical trials | — | Evidence |
Linked clinical programs
| Program | Phase | Sponsor | NCT |
|---|---|---|---|
| COOPERATION 2.0 | Phase 2 | Telethon Foundation | 2024-516304-42-00 |
| ACE001-RI001 | Phase 1 | ZhongShan Hospital, Fudan | NCT07570836 |
| APHP200034 | Phase 1 | PARItec | 2024-512231-72-00 |
| Extracellular Vesicles from Mesenchymal Stem Cells | Phase 1 | Regeneron Ireland Designated | NCT05787288 |
| Tolvaptan | Approved | Otsuka Beijing Research | NCT01552590 |
Related patents
| Number | Title | Jurisdiction |
|---|---|---|
| 12365719 | CD80 extracellular domain polypeptides and their use in cancer treatment | US |
| 12090175 | Compositions and methods for tissue repair with extracellular matrices | US |
| 12017066 | Modulation of extracellular vesicles with electrical stimulation | US |
| 11998635 | Targeted extracellular vesicles comprising membrane proteins with engineered glycosylation sites | US |
| 11801268 | Methods of treating ocular inflammation and chemical injuries of the eye with extracellular vesicles | US |
| 11786635 | Extracellular matrix for treating pelvic floor disorders and skeletal muscle degeneration | US |
| 11717480 | Extracellular vesicles and methods and uses thereof | US |
| 11491115 | Nanoparticles containing extracellular matrix for drug delivery | US |
| 11459593 | Dendrobium officinale endophytic fungus strain and extracellular polysaccharide produced thereby, and extraction method and application of extracellular polysaccharide | US |
| 11376346 | Extracellular matrix for treating pelvic floor disorders and skeletal muscle degeneration | US |
| 11191780 | Extracellular matrix compositions for the treatment of cancer or immunological diseases | US |
| 11098103 | CD80 extracellular domain polypeptides and their use in cancer treatment | US |
Related hubs
FAQ
What is the TGA / PMDA / NMPA approval status of extracellular?
extracellular currently shows NMPA clinical trials in our Asia-Pacific regulatory index. Confirm on the official TGA / PMDA / NMPA label or EPAR before clinical or commercial use.
Where does NovaPharmaNews get extracellular regulatory data?
Status fields are joined from public sources (openFDA / EMA / regional agencies), ClinicalTrials.gov-linked programs, and patent registries. See /about/data-sources for attribution.
How many clinical programs are linked to extracellular?
This spoke lists 5 published programs associated with extracellular in our pipeline index.